Skip to main content

Table 1 Subject demographics and BAL cell counts

From: Sarcoidosis activates diverse transcriptional programs in bronchoalveolar lavage cells

Subject Gender Age Race Smoking Stage Mac (%) Lymph (%) Pmn (%) Eos (%)
Sarc 1 M 52 AA Former 3 68 32 0 0
Sarc 2 F 32 AA Former 3 67 30 3 0
Sarc 3 F 39 AA Never 2 89 10 1 0
Sarc 4 F 61 AA Never NA 64 35 1 0
Sarc 5 M 57 AA Former 3 95 4 0 1
Sarc 6 M 68 AA Never 4 86 14 0 0
Sarc 7 F 62 AA Never 0 53 47 0 0
Sarc 8 M 34 AA Never 2 91 8 1 0
Sarc 9 F 47 AA Former 4 97 3 0 0
Sarc 10 M 48 AA Never 2 61 37 2 0
Sarc 11 F 53 C Never 2 96 4 0 0
Sarc 12 F 39 AA Never 2 70 30 0 0
Sarc 13 F 42 AA Former 1 85 15 0 0
Sarc 14 F 46 AA Never 2 67 9 24 0
Sarc 15 M 49 AA Former 2 94 5 0 1
Cont 1 M 27 AA Never 92 5 3 0
Cont 2 M 28 AA Never 98 2 0 0
Cont 3 F 51 C Never 92 8 0 0
Cont 4 F 31 AA Never 92 8 0 0
Cont 5 F 26 AA Never 91 4 3 2
Cont 6 F 24 AA Never 95 5 0 0
Cont 7 F 28 AA Never 98 1 0 1
Cont 8 M 28 C Never 98 2 0 0
Cont 9 F 26 AA Never 98 2 0 0
Cont 10 F 27 AA Never 97 3 0 0
Cont 11 M 30 AA Never 95 5 0 0
Cont 12 F 35 AA Never 93 7 0 0
  1. Sarc sarcoidosis patient, Cont control subject, AA African American, C Caucasian, Mac macrophage, Lymph lymphocyte, Pmn polymorphonuclear cell, Eos eosinophil